In response to genotoxic stress, a transient arrest in cell-cycle progression enforced by the DNA-damage checkpoint (DDC) signalling pathway positively contributes to genome maintenance 1 . Because hyperactivated DDC signalling can lead to a persistent and detrimental cell-cycle arrest 2,3 , cells must tightly regulate the activity of the kinases involved in this pathway. Despite their importance, the mechanisms for monitoring and modulating DDC signalling are not fully understood. Here we show that the DNA-repair scaffolding proteins Slx4 and Rtt107 prevent the aberrant hyperactivation of DDC signalling by lesions that are generated during DNA replication in Saccharomyces cerevisiae. On replication stress, cells lacking Slx4 or Rtt107 show hyperactivation of the downstream DDC kinase Rad53, whereas activation of the upstream DDC kinase Mec1 remains normal. An Slx4-Rtt107 complex counteracts the checkpoint adaptor Rad9 by physically interacting with Dpb11 and phosphorylated histone H2A, two positive regulators of Rad9-dependent Rad53 activation. A decrease in DDC signalling results from hypomorphic mutations in RAD53 and H2A and rescues the hypersensitivity to replication stress of cells lacking Slx4 or Rtt107. We propose that the Slx4-Rtt107 complex modulates Rad53 activation by a competition-based mechanism that balances the engagement of Rad9 at replication-induced lesions. Our findings show that DDC signalling is monitored and modulated through the direct action of DNA-repair factors.
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Slx4 is an evolutionarily conserved DNA-repair scaffolding protein that is important for the cellular response to exogenous DNAdamaging agents [4] [5] [6] [7] , and mutations in human SLX4 were recently linked to Fanconi anaemia 8, 9 . In S. cerevisiae (budding yeast), cells that lack SLX4 (slx4D cells) are highly sensitive to methyl methanesulphonate (MMS) 7 , a DNA-alkylating agent that blocks replication and induces the DDC pathway. While investigating the activation status of the S. cerevisiae DDC kinase Rad53 in slx4D cells, we noted that MMS treatment leads to hyperphosphorylation, and thus hyperactivation, of Rad53 compared with in wild-type cells ( Fig. 1a and Supplementary  Fig. 1a ), which is consistent with a previous report 10 . However, the phosphorylation of histone H2A (also known as Hta1 and Hta2), a substrate of the upstream DDC kinase Mec1, at serine 129 (here referred to as H2A pS129 ) was not increased in slx4D cells ( Fig. 1a, lower panel) . These results suggest that the hyperactivation of Rad53 in slx4D cells is not caused by increased damage-induced Mec1 signalling but by improper downstream regulation of Rad53 activation. To test this possibility, we compared the phosphoproteome of wild-type and slx4D cells after MMS treatment, using quantitative mass spectrometry. Although most of the detected Mec1 targets were phosphorylated to the same extent in both cell types, Rad53-dependent phosphorylation was significantly higher in slx4D cells than in wild-type cells ( Supplementary  Fig. 1b ), further supporting the idea that Slx4 has a role in specifically blocking Rad53 hyperactivation. Because the activation of Rad53 in response to MMS mostly depends on the checkpoint adaptor Rad9 ( Fig. 1b and Supplementary Fig. 2 ), Slx4 probably counteracts Rad9dependent Rad53 activation.
To test whether the sensitivity of slx4D cells to MMS is caused mostly by aberrant Rad53 hyperactivation, we used hypomorphic alleles of rad53 that result in lower Rad53 activation, reasoning that these alleles would rescue the MMS sensitivity of slx4D cells. Rad53 has two FHA domains, which bind to phosphorylated Rad9 in a redundant manner and mediate Rad53 activation 11 (Fig. 1c ). Mutations in the FHA2 domain promote a stronger reduction in MMS-induced Rad53 activation than do mutations in the FHA1 domain 12 . Whereas a mutation (R70A, in which arginine is substituted with alanine at amino acid 70) in the FHA1 domain of Rad53 had no effect on the MMS sensitivity of slx4D cells, a mutation (R605A) in the FHA2 domain reduced the MMS sensitivity of slx4D cells ( Fig. 1d ). Consistent with our hypothesis that Rad53 hyperactivation is the cause of the MMS sensitivity of slx4D cells, mutation of the FHA2 domain resulted in a decrease in Rad53 activation in slx4D cells to a level similar to that of wild-type cells ( Fig. 1e ). Collectively, these results suggest that Slx4 has a crucial role in preventing excessive Rad9-dependent activation of Rad53 (Fig. 1f ). The levels of MMS used here require that cells pass through the S phase of the cell cycle for Rad53 to become active 13 ; therefore, our results suggest that Slx4 counteracts the Rad9-Rad53 pathway in response to replication-induced lesions. The finding that combined deletion of the SLX1 and RAD1 genes, which encode nucleases that are known to associate with Slx4, leads to lower MMS sensitivity and Rad53 activation than in slx4D cells ( Supplementary Fig. 4 ) supports a nucleaseindependent function for Slx4 during the cellular response to MMSinduced replication stress.
We recently reported that on replication stress, Slx4 binds to Dpb11 (ref. 14) , a replication factor that is involved in DDC activation 15, 16 . Because Dpb11 binds to Rad9 and positively regulates Rad9-dependent Rad53 activation 17,18 , we assessed whether the Slx4-Dpb11 interaction has a role in counteracting Rad53 activation during MMS treatment. We previously showed that phosphorylation of Slx4 by Mec1 mediates the interaction of Slx4 with Dpb11 and that an Slx4 mutant lacking seven Mec1 consensus phosphorylation sites (Slx4-7MUT) cannot stably interact with Dpb11 (ref. 14) . Rad53 is hyperactivated in slx4-7MUT cells ( Fig. 2a ), supporting a model in which the Slx4-Dpb11 interaction is important for preventing Rad53 hyperactivation.
Next, we tested whether the Slx4-Dpb11 interaction inhibits the ability of Rad9 to bind to Dpb11 in wild-type and slx4D cells. Deletion of SLX4 leads to a significant increase in the MMS-induced interaction between Dpb11 and Rad9 ( Fig. 2b and Supplementary Fig. 5 ), suggesting that Slx4 and Rad9 compete for Dpb11 binding. Dpb11 contains two pairs of BRCT domains, which bind to phosphorylated motifs. We found that recombinant BRCT domains 1 and 2 (BRCT 1/2 ) of Dpb11 can bind phosphorylated Slx4 and phosphorylated Rad9 from MMS-treated S. cerevisiae lysates (Fig. 2c ). This finding is consistent with a model in which Slx4 and Rad9 compete for BRCT 1/2 binding. Dpb11 BRCT 1/2 was previously shown to interact directly with cyclin-dependent kinase (CDK)-dependent phosphorylation sites in Sld3, thereby initiating DNA replication 19, 20 . To better understand the mechanism of the Slx4-Dpb11 interaction, we searched for a CDK-targeting motif in Slx4 that resembles the Dpb11-binding region in Sld3. Notably, Slx4 contains proline-directed phosphorylation sites that align well with serine 600 (S600) and S622 of Sld3, which are important for the Dpb11-Sld3 interaction 19, 20 ( Supplementary Fig. 6 ). We tested the importance of the proline-directed sites within the Sld3-like region of Slx4 and found that S486 of Slx4 is crucial for the MMS-induced interaction with Dpb11 ( Fig. 2d ). In addition, three canonical Mec1 phosphorylation sites (S/T-Q sites) that are important for mediating a robust Slx4-Dpb11 interaction 14 are located in or near the Sld3-like Dpb11-binding region in Slx4. We conclude that the Slx4-Dpb11 interaction is mediated by the coordinated action of both Mec1 and a proline-directed kinase at a motif that is probably targeted by BRCT 1/2 of Dpb11. Although we detected residual binding between Dpb11 and Slx4-7MUT, we did not detect an interaction between Dpb11 and Slx4 S486A , suggesting that the phosphorylation of S486 has a more important role in mediating the Slx4-Dpb11 interaction than the Mec1 consensus phosphorylation sites. This is also supported by the finding that slx4 S486A leads to Rad53 hyperactivation ( Fig. 2e ) and to a higher MMS sensitivity than does slx4-7MUT ( Fig. 2f ). Interestingly, previous reports showed that proline-directed sites in Rad9 are also important for the Dpb11-Rad9 interaction 17, 18 (Supplementary Fig. 7) .
To further test the model that Slx4 antagonizes Rad53 activation by binding to Dpb11 and outcompeting Rad9, we overexpressed Slx4 using an ADH1 or a TDH3 promoter and monitored different steps of checkpoint activation. In an early step in checkpoint activation, Rad9 assembles into a ternary complex with Dpb11 and Mec1 and is hyperphosphorylated by Mec1 (ref. 18 ). We first monitored the phosphorylation status of Rad9 in cells expressing Slx4 from its endogenous promoter and in cells overexpressing Slx4. Overexpression of wildtype Slx4 but not S486A mutated Slx4 significantly inhibited the MMSinduced hyperphosphorylation of Rad9 ( Fig. 2g ), as shown by the strong decrease in the slower migrating band at 45 and 60 min after release from a-factor arrest. We then monitored the effect of Slx4 overexpression on Rad53 activation in response to MMS treatment ( Supplementary Fig. 8a ). Although overexpression of Slx4 leads to a small but consistent decrease in Rad53 activation early in the response, we did not observe the same effect at later time points. We speculated that after 40 min, the Rad53 activation that was observed in Slx4overexpressing cells was being mediated by a parallel mechanism based on Dot1-mediated histone H3K79 methylation, which can promote the recruitment of Rad9 to lesion sites independently of Dpb11 (ref. 21) . We therefore monitored Rad53 activation in cells lacking DOT1 and found that Slx4 overexpression significantly reduces Rad53 activation also at later time points (Fig. 2h) ; this effect depends on S486 of Slx4 ( Supplementary Fig. 8b, c) . Next, we determined whether Slx4 overexpression specifically disrupts the Rad9-Dpb11 interaction. We detected hyperphosphorylated Rad9 in a Dpb11 pulldown from cells expressing Slx4 from its endogenous promoter, but we did not detect Rad9 in a Dpb11 pull-down using cells that overexpressed Slx4 (Fig. 2i ). This effect was specific for S486 of Slx4. These findings support our model that Slx4 counteracts DDC signalling by binding to Dpb11 and preventing its stable interaction with Rad9 (Fig. 2j ).
Slx4 forms a tight complex with the BRCT-domain-containing protein Rtt107, which is a DNA-repair scaffold that stabilizes the Slx4-Dpb11 interaction 14 . Analysis of the phosphorylation status of Rad53 in rtt107D cells showed that DDC signalling is hyperactivated (Fig. 3a ), suggesting that Rtt107 has a similar function to Slx4 in counteracting proteins. Similar results were obtained with strains containing untagged Rad53 ( Supplementary Fig. 3 ). e, Western blot showing the phosphorylation status of Rad53-Flag in the indicated strains after MMS treatment. f, Model for the role of Slx4 in uncoupling Rad53 activation from Mec1 signalling, through counteracting Rad9. Rad53-p, phosphorylated Rad53; WT, wild type.
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Rad53 activation. Rtt107 recognizes H2A pS129 through its carboxyterminal pair of BRCT domains (BRCT 5/6 ), and this region is essential for the role of Rtt107 in the MMS response 22 (Supplementary Figs 9  and 10 ). Furthermore, the S129A mutation (h2a-S129A) abrogated Slx4 phosphorylation on MMS treatment (Fig. 3b ), suggesting that the recruitment of Rtt107 to H2A pS129 occurs upstream of Slx4-Dpb11 complex formation. Because H2A pS129 can function as a positive regulator of Rad9-dependent Rad53 activation 23 , we reasoned that the hyperactivation of Rad53 in rtt107D cells could be suppressed by h2a-S129A. rtt107D cells expressing the H2A(S129A) mutant had lower Rad53 activation and MMS sensitivity than did rtt107D cells expressing wild-type H2A (Fig. 3c, d) . Disruption of the Rad9-H2A interaction by mutation of the C-terminal pair of BRCT domains of Rad9 (K1088M) partially rescued the MMS sensitivity of rtt107D cells ( Supplementary  Fig. 11a ). A similar rescue was also observed when overexpressing BRCT 5/6 of Rtt107 ( Supplementary Fig. 11b ). Taken together, these results show that, like Slx4, Rtt107 also counteracts DDC signalling. The anti-checkpoint function of Rtt107 depends on its recognition of H2A pS129 , a step that is required subsequently for the assembly of the Slx4-Dpb11 complex. Thus, the Slx4-Rtt107 complex functions as a negative regulator of activation of the kinase Rad53 by physically interacting with two positive regulators of the adaptor Rad9: Dpb11 and H2A pS129 .
To further test the anti-checkpoint function of the Slx4-Rtt107 complex, we developed an alternative experimental set-up in which the presence of Slx4 would sensitize cells to replication stress by decreasing DDC signalling below the level required for a proper cellular response. For this set-up, we used cells lacking Mrc1, which is a checkpoint adaptor that works in parallel with Rad9. Mrc1 mediates Rad53 activation at stalled replication forks and therefore has a more Fig. 1a . f, MMS sensitivity assay on the indicated slx4 mutants. g, Rad9 phosphorylation status in cells expressing WT or mutant Slx4 from the endogenous SLX4 promoter or the ADH1 promoter. h, Rad53 phosphorylation status in dot1D cells expressing Slx4 from the endogenous SLX4 promoter or the TDH3 promoter. Cells were arrested in a-factor and released for 45 min in medium containing MMS. i, Co-IP of Dpb11 and Rad9. j, Model for the mechanism by which Slx4 counteracts Rad53 activation. G1, G1 cell-cycle phase; Rad9-p, hypophosphorylated Rad9; Rad9-ppp, hyperphosphorylated Rad9; WCE, whole cell extract.
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central role than Rad9 in Rad53 activation in response to hydroxyurea 24 . On hydroxyurea treatment, mrc1D cells rely solely on Rad9 to activate Rad53. The interaction of Slx4 with Dpb11 was enhanced in mrc1D cells (Fig. 4a ), especially in response to hydroxyurea, suggesting that the Slx4-Rtt107 complex actively counteracts Rad9 in mrc1D cells (Fig. 4b) . Consistent with our finding that the Slx4-Dpb11 interaction requires H2A pS129 , high levels of H2A pS129 accumulated close to the origins of replication in mrc1D cells after hydroxyurea treatment (Fig. 4c ). Because we expect that the kinase activity of Rad53 is limiting in mrc1D cells, we reasoned that deletion of SLX4 would be beneficial in hydroxyurea-treated mrc1D cells, allowing more activation of Rad53 through Rad9. Consistent with this idea, mrc1Dslx4D cells had a significantly higher hydroxyurea resistance than mrc1D cells (Fig. 4d ), and this resistance correlated with higher Rad53 activation (Fig. 4e ). Taken together, these results show that Slx4 sensitizes mrc1D cells to replication stress, and they provide strong additional evidence that the Slx4-Rtt107 complex counteracts Rad9 in response to replication-induced lesions (see detailed model in Supplementary Fig. 12 ). Because this function of the Slx4-Rtt107 complex depends on Mec1dependent phosphorylation, we propose that Slx4-Rtt107 is involved in a mechanism that we have named DAMP -dampens checkpoint adaptor-mediated phospho-signalling -by which DDC signalling self-monitors its activation state. We speculate that by uncoupling upstream Mec1 signalling from downstream Rad53 activation, DAMP could allow Mec1 to maintain control over specific effectors, such as repair enzymes, without an aberrant arrest in cell-cycle progression.
METHODS SUMMARY
The yeast strains and plasmids used are described in Supplementary Tables 3 and  4 . The mass-spectrometry-based phosphorylation analyses of whole cell lysates or purified Rad53, as well as the other procedures used for cell growth and synchronization, genotoxin treatment and chromatin immunoprecipitation analysis, are detailed in the Methods.
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